JP2005506300A5 - - Google Patents

Download PDF

Info

Publication number
JP2005506300A5
JP2005506300A5 JP2002578411A JP2002578411A JP2005506300A5 JP 2005506300 A5 JP2005506300 A5 JP 2005506300A5 JP 2002578411 A JP2002578411 A JP 2002578411A JP 2002578411 A JP2002578411 A JP 2002578411A JP 2005506300 A5 JP2005506300 A5 JP 2005506300A5
Authority
JP
Japan
Prior art keywords
seq
peptide
residue
cells
leucine
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2002578411A
Other languages
English (en)
Japanese (ja)
Other versions
JP4310107B2 (ja
JP2005506300A (ja
Filing date
Publication date
Priority claimed from US09/820,053 external-priority patent/US6875744B2/en
Application filed filed Critical
Priority claimed from PCT/US2002/009534 external-priority patent/WO2002079408A2/en
Publication of JP2005506300A publication Critical patent/JP2005506300A/ja
Publication of JP2005506300A5 publication Critical patent/JP2005506300A5/ja
Application granted granted Critical
Publication of JP4310107B2 publication Critical patent/JP4310107B2/ja
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

JP2002578411A 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法 Expired - Lifetime JP4310107B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US27950501P 2001-03-28 2001-03-28
US09/820,053 US6875744B2 (en) 2001-03-28 2001-03-28 Short bioactive peptides
PCT/US2002/009534 WO2002079408A2 (en) 2001-03-28 2002-03-28 Short bioactive peptides and methods for their use

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2009004309A Division JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Publications (3)

Publication Number Publication Date
JP2005506300A JP2005506300A (ja) 2005-03-03
JP2005506300A5 true JP2005506300A5 (enExample) 2005-12-22
JP4310107B2 JP4310107B2 (ja) 2009-08-05

Family

ID=26959709

Family Applications (2)

Application Number Title Priority Date Filing Date
JP2002578411A Expired - Lifetime JP4310107B2 (ja) 2001-03-28 2002-03-28 生物活性を有する短ペプチド及び該ペプチドの使用方法
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2009004309A Expired - Lifetime JP4484941B2 (ja) 2001-03-28 2009-01-13 生物活性を有する短ペプチド及び該ペプチドの使用方法

Country Status (8)

Country Link
US (1) US7381704B2 (enExample)
EP (2) EP1379265A4 (enExample)
JP (2) JP4310107B2 (enExample)
KR (1) KR100891157B1 (enExample)
AU (1) AU2002255952A1 (enExample)
CA (1) CA2441562C (enExample)
ES (1) ES2389285T3 (enExample)
WO (1) WO2002079408A2 (enExample)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA2521979A1 (en) * 2003-04-09 2004-10-28 University Of Utah Research Foundation Compositions and methods related to production of erythropoietin
JP2005281225A (ja) * 2004-03-30 2005-10-13 Japan Science & Technology Agency 新規塩基性抗菌ペプチド及びその利用
US20090220435A1 (en) * 2005-07-27 2009-09-03 Nastech Pharmaceutical Company Inc. Tight junction modulating peptide components for enhancing mucosal delivery of therapeutic agents
US7601361B2 (en) * 2005-10-03 2009-10-13 E. I. Du Pont De Nemours And Company Process for providing antimicrobial surfaces
JP5173838B2 (ja) 2006-02-13 2013-04-03 アレシア・バイオセラピューティクス・インコーポレーテッド 骨リモデリングのプロセスと関係があるポリヌクレオチドおよびポリペプチド配列
US8168181B2 (en) 2006-02-13 2012-05-01 Alethia Biotherapeutics, Inc. Methods of impairing osteoclast differentiation using antibodies that bind siglec-15
KR101552453B1 (ko) * 2006-06-01 2015-09-11 데라퓨틱 펩타이즈, 인코포레이션 중합성 생계면활성제
PL2027152T3 (pl) 2006-06-13 2012-04-30 Helix Biomedix Inc Fragmenty peptydów do indukowania syntezy białek macierzy zewnątrzkomórkowej
KR100742982B1 (ko) * 2006-06-22 2007-07-26 케이맥(주) 초점 타원계측기
EP2125878B1 (en) * 2007-01-05 2013-02-20 Helix Biomedix, Inc. Short bio-active peptides for cellular and immunological modulation
EP2152726B8 (en) * 2007-05-01 2015-02-18 Fundação de Amparo à Pesquisa do Estado de São Paulo - FAPESP Analgesic compounds
PL2205623T3 (pl) 2007-10-29 2016-09-30 Ochronne tetrapeptydy do pielęgnacji skóry
GB0803352D0 (en) 2008-02-22 2008-04-02 Ntnu Technology Transfer As Oligopeptidic compounds and uses thereof
EP2168591A1 (en) * 2008-09-24 2010-03-31 Helmholtz Zentrum München Deutsches Forschungszentrum für Gesundheit und Umwelt (GmbH) Antimicrobial peptides
US20120270770A1 (en) * 2010-08-03 2012-10-25 Jesse Michael Jaynes Anti-angiogenic peptides and their uses
AU2013293062A1 (en) 2012-07-19 2014-07-24 Alethia Biotherapeutics Inc. Anti-Siglec-15 antibodies
ITBS20120126A1 (it) * 2012-08-01 2014-02-02 Paoli Ambrosi Gianfranco De Composizione antibatterica per uso topico
CN105283198A (zh) * 2013-04-09 2016-01-27 卡勒德·莫希·埃尔丹·伊罗丹 作为恶性肿瘤控制中的单一疗法的新型肽
GB201319620D0 (en) 2013-11-06 2013-12-18 Norwegian University Of Science And Technology Immunosuppressive agents and their use in therapy
EP3206703B1 (en) * 2014-10-14 2021-05-19 The U.S.A. As Represented By The Secretary, Department Of Health And Human Services Peptide for treating pancreatic cancer
CN105061562B (zh) * 2015-09-16 2018-01-12 山东电力中心医院 一种具有抗肺癌作用的寡肽及其应用
US9439917B1 (en) * 2015-12-28 2016-09-13 Shetal Amit Shah Anti-blepharitis compositions and their use
CN109069578A (zh) 2016-02-29 2018-12-21 达纳-法伯癌症研究所股份有限公司 用于治疗感染的钉合的细胞内靶向抗微生物肽
AU2018304230A1 (en) 2017-07-19 2020-02-06 Dana-Farber Cancer Institute, Inc. Stabilized anti-microbial peptides for the treatment of antibiotic-resistant bacterial infections
CN112040968B (zh) * 2018-04-30 2024-01-30 欧莱雅 对人肌肉烟碱性乙酰胆碱受体具有高结合亲和力的生物活性肽
KR20210151945A (ko) 2019-04-12 2021-12-14 립타이드 바이오사이언스, 인코포레이티드 대식세포 활성을 조정하기 위한 방법
FR3099060B1 (fr) * 2019-07-26 2022-01-14 Bionuclei Complexe hybride mineral et organique et son utilisation pour le maintien de l’equilibre microbiologique de la peau et/ou d’une composition cosmetique et/ou dermopharmaceutique
TR2023016596A2 (tr) * 2023-12-06 2024-01-22 Karadeniz Teknik Ueniversitesi Teknoloji Transferi Uygulama Ve Arastirma Merkezi Mueduerluegue Anti̇bi̇yoti̇klere alternati̇f yeni̇ ki̇tosan konjuge anti̇mi̇krobi̇yal pepti̇ti̇n geli̇şti̇ri̇lmesi̇
AU2025212440A1 (en) * 2024-01-25 2026-07-02 Lipotrue, S.L. Peptides and cosmetic compositions for use in the treatment of acne and its related skin conditions
CN120209088B (zh) * 2025-03-07 2026-03-03 黄小柯 一种多效蛋白mel3及其应用

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4520016A (en) * 1980-06-17 1985-05-28 Kabigen Ab Bacteriolytic proteins
US4355104A (en) 1980-06-17 1982-10-19 Kabigen Ab Bacteriolytic proteins
DE3854476T2 (de) * 1987-07-06 1996-04-04 Univ Louisiana State Inhibierung von eukaryotischen pathogenen und neoplasmen mit lytischen peptiden.
CA1327311C (en) * 1987-07-06 1994-03-01 Jesse M. Jaynes Therapeutic antimicrobial polypeptides, their use and methods for preparation
US5861478A (en) * 1987-07-06 1999-01-19 Helix Biomedix, Inc. Lytic peptides
WO1990012866A1 (en) * 1989-04-10 1990-11-01 Louisiana State University And Agricultural And Mechanical College Lytic peptides, use for growth, infection and cancer
CA2107674A1 (en) * 1991-04-08 1992-10-09 W. Lee Maloy Novel peptide compositions and uses therefor
US5955573A (en) 1993-06-04 1999-09-21 Demegen, Inc. Ubiquitin-lytic peptide fusion gene constructs, protein products deriving therefrom, and methods of making and using same
WO1994028921A1 (en) * 1993-06-04 1994-12-22 Demeter Biotechnologies, Ltd. Method of treating pulmonary disease states with non-naturally occurring amphipathic peptides
US5561107A (en) * 1993-06-04 1996-10-01 Demeter Biotechnologies, Ltd. Method of enhancing wound healing by stimulating fibroblast and keratinocyte growth in vivo, utilizing amphipathic peptides
AU1086595A (en) * 1993-11-08 1995-05-29 Demeter Biotechnologies, Ltd. Methylated lysine-rich lytic peptides and method of making same by reductive alkylation
US5789542A (en) * 1994-04-22 1998-08-04 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Amphipathic peptides
IL114697A0 (en) 1994-07-22 1995-11-27 Demeter Biotech Ltd Polypeptides comprising ubiquitin-lytic peptide fusion protein products deriving therefrom their preparation and use
EP0866805A1 (en) * 1995-12-12 1998-09-30 Karolinska Innovations AB PEPTIDE BINDING THE KLVFF-SEQUENCE OF AMYLOID $g(b)
US6566334B1 (en) * 1997-02-06 2003-05-20 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Short amphipathic peptides with activity against bacteria and intracellular pathogens
US6635740B1 (en) * 1997-03-27 2003-10-21 Board Of Supervisors Of Louisiana State University And Agricultural And Mechanical College Ligand/lytic peptide compositions and methods of use
US6958212B1 (en) * 1999-02-01 2005-10-25 Eidgenossische Technische Hochschule Zurich Conjugate addition reactions for the controlled delivery of pharmaceutically active compounds
EP1254167A2 (en) 2000-01-06 2002-11-06 Monsanto Technology LLC Preparation of deallergenized patatin proteins and patatin permutein proteins

Similar Documents

Publication Publication Date Title
Smith et al. Antibiotic delivery strategies to treat skin infections when innate antimicrobial defense fails
Jin et al. Synergistic and on-demand release of Ag-AMPs loaded on porous silicon nanocarriers for antibacteria and wound healing
Zhou et al. A review on nanosystems as an effective approach against infections of Staphylococcus aureus
Gawande et al. Antibiofilm and antimicrobial efficacy of DispersinB®-KSL-W peptide-based wound gel against chronic wound infection associated bacteria
JP5969457B2 (ja) 化合物およびそれらの使用
AU760870B2 (en) Method and composition for the treatment of epidermal irritations and infections
US20190350970A1 (en) Topical Antimicrobial Formulations Containing Monovalent Copper Ions And Systems For Generating Monovalent Copper Ions
JP2017525676A5 (enExample)
Vijayan et al. Multiple cargo deliveries of growth factors and antimicrobial peptide using biodegradable nanopolymer as a potential wound healing system
JP6964577B2 (ja) 抗菌性ペプチド及びその使用方法
KR100891157B1 (ko) 짧은 생물활성 펩티드 및 그것들의 사용 방법
Wernicki et al. Antimicrobial properties of gold, silver, copper and platinum nanoparticles against selected microorganisms isolated from cases of mastitis in cattle
CA2468916A1 (en) A stable oxaliplatin solution formulation
JP2002526407A5 (enExample)
JP2018513186A5 (enExample)
WO1998006419A1 (en) Enhancement of antimicrobial peptide activity by metal ions
BR0317564A (pt) Compostos, composições e métodos para tratar doenças causadas por bactérias ou fungos
JP2003508416A (ja) 金属含有組成物、その製法および用法
US20250090627A1 (en) Nutritional polypeptide having branched-structure with efficient broad-spectrum antibacterial and antifungal functions
Griffith et al. Anti-microbiological and anti-infective activities of silver
WO2015181551A1 (en) Gold (i)-phosphine compounds as anti-bacterial agents
CN106589088A (zh) 一种具有抗菌抗炎活性的多肽及其应用
WO2002102311A3 (en) Nanoparticles for treating targeted tissues and cells
AU2001289641A1 (en) Method for producing and using novel human defensins as biologically active proteins for treating infections and other illnesses
Osak et al. Chitosan as a drug carrier